PharmaPendium 2023.24 Release

The content release includes the following updates:

8 new drugs in PharmaPendium

Capivasertib
Efbemalenograstim Alfa
Fruquintinib
Nirogacestat Hydrobromide
Repotrectinib
Sitagliptin; Metformin Hydrochloride
Taurolidine; Heparin Sodium
Vonoprazan Fumarate

FDA Approval Documents:

224 new FDA Approval Documents
2,920 new pages of FDA Approval Documents

FDA Advisory Committee Documents:

176 new FDA Advisory Committee Documents
3,964 new pages of FDA Advisory Committee Documents

The new totals for PharmaPendium are:

3,136,545 pages of FDA Approval documents (Including FDA Classic Collection)
153,389 documents of FDA Approval documents (Including FDA Classic Collection)
4,925 drugs with data in PharmaPendium
2,471,778 extracted safety data lines
2,347,648 extracted PK data lines
620,866 extracted ME data lines
3,987,017 extracted Efficacy data lines
184,226 extracted Activity data lines
21,438,356 FAERS (post-marketing) reports
19,092 documents / 411,698 pages of EMA Approval documents
21,797 documents / 825,423 pages of FDA Advisory Committees Meetings documents
10,906 documents / 308,149 pages of FDA Classic Collection
2,769 documents / 32,290 pages of DESI documents

PharmaPendium 2023.23 Release

The content release includes the following updates:

3 new drugs in PharmaPendium

Anthrax Vaccine Adsorbed, Adjuvanted
Prothrombin Complex Concentrate, Human-Lans
Tislelizumab

FDA Approval Documents:

332 new FDA Approval Documents
4,939 new pages of FDA Approval Documents

EMA Documents:

69 new EMA documents
2,755 new pages of EMA Documents

Extracted PK data observations:

5,139 new extracted PK data lines

Extracted Safety data observations:

4,849 new extracted safety data lines

Metabolizing Enzymes Database:

1,600 new ME extracted data lines

Published Toxicity Database:

706 new safety records

The new totals for PharmaPendium are:

3,133,625 pages of FDA Approval documents (Including FDA Classic Collection)
153,165 documents of FDA Approval documents (Including FDA Classic Collection)
4,917 drugs with data in PharmaPendium
2,471,778 extracted safety data lines
2,347,658 extracted PK data lines
619,871 extracted ME data lines
3,987,017 extracted Efficacy data lines
184,226 extracted Activity data lines
21,438,357 FAERS (post-marketing) reports
19,092 documents / 411,698 pages of EMA Approval documents
21,621 documents / 821,459 pages of FDA Advisory Committees Meetings documents
10,906 documents / 308,149 pages of FDA Classic Collection
2,769 documents / 32,290 pages of DESI documents

PharmaPendium 2023.22 Release

The content release includes the following updates:

9 new drugs in PharmaPendium

Clindamycin Phosphate; Adapalene; Benzoyl Peroxide
Etrasimod
Gepirone Hydrochloride
Nedosiran Sodium
Sitagliptin
Technetium Tc-99m Labeled Carbon
Toripalimab
Vamorolone
Zilucoplan

FDA Approval Documents:

347 new FDA Approval Documents
6,007 new pages of FDA Approval Documents

FAERS:

405,174 new FAERS reports (2023_Q3)

The new totals for PharmaPendium are:

3,128,686 pages of FDA Approval documents (Including FDA Classic Collection)
152,833 documents of FDA Approval documents (Including FDA Classic Collection)
4,914 drugs with data in PharmaPendium
2,466,223 extracted safety data lines
2,342,519 extracted PK data lines
618,271 extracted ME data lines
3,987,017 extracted Efficacy data lines
184,226 extracted Activity data lines
21,438,357 FAERS (post-marketing) reports
19,023 documents / 408,943 pages of EMA Approval documents
21,621 documents / 821,459 pages of FDA Advisory Committees Meetings documents
10,906 documents / 308,149 pages of FDA Classic Collection
2,769 documents / 32,290 pages of DESI documents

PharmaPendium 2023.21 Release

1 new drug in PharmaPendium

Gefapixant Citrate

FDA Approval Documents:

401 new FDA Approval Documents
5,439 new pages of FDA Approval Documents

EMA Documents:

101 new EMA documents
620 updated EMA documents
3,151 new pages of EMA Documents

Extracted PK data observations:

5,433 new extracted PK data lines

Extracted Safety data observations:

10,345 new extracted safety data lines

Metabolizing Enzymes Database:

4,153 new ME extracted data lines

Published Toxicity Database:

498 new safety records

Efficacy Database:

28,128 new extracted data lines

The new totals for PharmaPendium are:

3,122,679 pages of FDA Approval documents (Including FDA Classic Collection)
152,486 documents of FDA Approval documents (Including FDA Classic Collection)
4,905 drugs with data in PharmaPendium
2,466,223 extracted safety data lines
2,342,519 extracted PK data lines
618,266 extracted ME data lines
3,987,017 extracted Efficacy data lines
184,226 extracted Activity data lines
21,033,183 FAERS (post-marketing) reports
19,023 documents / 408,943 pages of EMA Approval documents
21,621 documents / 821,459 pages of FDA Advisory Committees Meetings documents
10,906 documents / 308,149 pages of FDA Classic Collection
2,769 documents / 32,290 pages of DESI documents

PharmaPendium 2023.20 Release

3 new drugs in PharmaPendium

Elranatamab
Momelotinib Dihydrochloride
Motixafortide Acetate

FDA Approval Documents:

534 new FDA Approval Documents
6,245 new pages of FDA Approval Documents

FDA Advisory Committee Documents:

85 new FDA Advisory Committee Documents
5,000 new pages of FDA Advisory Committee Documents

The new totals for PharmaPendium are:

3,117,240 pages of FDA Approval documents (Including FDA Classic Collection)
152,085 documents of FDA Approval documents (Including FDA Classic Collection)
4,904 drugs with data in PharmaPendium
2,455,380 extracted safety data lines
2,337,086 extracted PK data lines
614,113 extracted ME data lines
3,958,889 extracted Efficacy data lines
184,226 extracted Activity data lines
21,033,183 FAERS (post-marketing) reports
18,922 documents / 405,792 pages of EMA Approval documents
21,621 documents / 821,459 pages of FDA Advisory Committees Meetings documents
10,906 documents / 308,149 pages of FDA Classic Collection
2,769 documents / 32,290 pages of DESI documents

PharmaPendium 2023.19 Release

FDA Approval Documents:

327 new FDA Approval Documents
4,376 new pages of FDA Approval Documents

EMA Documents:

51 new EMA documents
2,632 new pages of EMA Documents

Extracted PK data observations:

4,503 new extracted PK data lines

Extracted Safety data observations:

4,787 new extracted safety data lines

Metabolizing Enzymes Database:

1,007 new ME extracted data lines

Published Toxicity Database:

472 new safety records

The new totals for PharmaPendium are:

3,110,995 pages of FDA Approval documents (Including FDA Classic Collection)
151,551 documents of FDA Approval documents (Including FDA Classic Collection)
4,901 drugs with data in PharmaPendium
2,455,513 extracted safety data lines
2,337,086 extracted PK data lines
614,113 extracted ME data lines
3,958,889 extracted Efficacy data lines
184,226 extracted Activity data lines
21,033,183 FAERS (post-marketing) reports
18,922 documents / 405,792 pages of EMA Approval documents
21,536 documents / 816,459 pages of FDA Advisory Committees Meetings documents
10,906 documents / 308,149 pages of FDA Classic Collection
2,769 documents / 32,290 pages of DESI documents

PharmaPendium 2023.18 Release

The content release includes the following updates:

7 new drugs in PharmaPendium

Avacincaptad Pegol Sodium
Delandistrogene Moxeparvovec
Donislecel
Palovarotene
Pozelimab
Talquetamab
Zuranolone

FDA Approval Documents:

206 new FDA Approval Documents
2,827 new pages of FDA Approval Documents

The new totals for PharmaPendium are:

3,106,619 pages of FDA Approval documents (Including FDA Classic Collection)
151,224 documents of FDA Approval documents (Including FDA Classic Collection)
4,901 drugs with data in PharmaPendium
2,450,254 extracted safety data lines
2,332,583 extracted PK data lines
613,106 extracted ME data lines
3,958,889 extracted Efficacy data lines
184,226 extracted Activity data lines
21,033,183 FAERS (post-marketing) reports
18,871 documents / 403,160 pages of EMA Approval documents
21,536 documents / 816,459 pages of FDA Advisory Committees Meetings documents
10,906 documents / 308,149 pages of FDA Classic Collection
2,769 documents / 32,290 pages of DESI documents

PharmaPendium 2023.17 Release

The content release includes the following updates:

1 new drug in PharmaPendium

Sitagliptin Fumarate; Metformin Hydrochloride

FDA Approval Documents:

391 new FDA Approval Documents
5,780 new pages of FDA Approval Documents

EMA Documents:

112 new EMA documents
632 updated EMA documents
4,213 new pages of EMA Documents

Extracted PK data observations:

6,354 new extracted PK data lines

Extracted Safety data observations:

10,992 new extracted safety data lines

Metabolizing Enzymes Database:

4,863 new ME extracted data lines

Published Toxicity Database:

605 new safety records

Efficacy Database:

47,288 new extracted data lines

The new totals for PharmaPendium are:

3,103,792 pages of FDA Approval documents (Including FDA Classic Collection)
151,018 documents of FDA Approval documents (Including FDA Classic Collection)
4,894 drugs with data in PharmaPendium
2,450,254 extracted safety data lines
2,332,583 extracted PK data lines
613,135 extracted ME data lines
3,958,889 extracted Efficacy data lines
184,226 extracted Activity data lines
21,033,183 FAERS (post-marketing) reports
18,871 documents / 403,160 pages of EMA Approval documents
21,536 documents / 816,459 pages of FDA Advisory Committees Meetings documents
10,906 documents / 308,149 pages of FDA Classic Collection
2,769 documents / 32,290 pages of DESI documents

PharmaPendium 2023.16 Release

Last updated on August 23, 2023

The content release includes the following updates:

4 new drugs in PharmaPendium

Beremagene Geperpavec
Cantharidin
Lotilaner
Respiratory Syncytial Virus Vaccine

FDA Approval Documents:

515 new FDA Approval Documents
5,799 new pages of FDA Approval Documents

FDA Advisory Committee Documents:

184 new FDA Advisory Committee Documents
4,661 new pages of FDA Advisory Committee Documents

FAERS:

416,330 new FAERS reports (2023_Q2)

The new totals for PharmaPendium are:

3,098,012 pages of FDA Approval documents (Including FDA Classic Collection)
150,627 documents of FDA Approval documents (Including FDA Classic Collection)
4,893 drugs with data in PharmaPendium
2,438,657 extracted safety data lines
2,326,229 extracted PK data lines
608,272 extracted ME data lines
3,911,601 extracted Efficacy data lines
184,226 extracted Activity data lines
21,033,176 FAERS (post-marketing) reports
18,759 documents / 398,947 pages of EMA Approval documents
21,536 documents / 816,459 pages of FDA Advisory Committees Meetings documents
10,906 documents / 308,149 pages of FDA Classic Collection
2,769 documents / 32,290 pages of DESI documents

PharmaPendium 2023.15 Release

The content release includes the following updates:

1 new drug in PharmaPendium

Mirikizumab

FDA Approval Documents:

472 new FDA Approval Documents
6,090 new pages of FDA Approval Documents

EMA Documents:

87 new EMA documents
4,039 new pages of EMA Documents

Extracted PK data observations:

2,569 new extracted PK data lines

Extracted Safety data observations:

4,287 new extracted safety data lines

Metabolizing Enzymes Database:

1,627 new ME extracted data lines

Published Toxicity Database:

717 new safety records

The new totals for PharmaPendium are:

3,092,213 pages of FDA Approval documents (Including FDA Classic Collection)
150,112 documents of FDA Approval documents (Including FDA Classic Collection)
4,889 drugs with data in PharmaPendium
2,438,657 extracted safety data lines
2,326,229 extracted PK data lines
608,272 extracted ME data lines
3,911,601 extracted Efficacy data lines
184,226 extracted Activity data lines
20,616,846 FAERS (post-marketing) reports
18,759 documents / 398,947 pages of EMA Approval documents
21,352 documents / 811,798 pages of FDA Advisory Committees Meetings documents
10,906 documents / 308,149 pages of FDA Classic Collection
2,769 documents / 32,290 pages of DESI documents

PharmaPendium 2023.14 Release

The content release includes the following updates:

6 new drugs in PharmaPendium

Efgartigimod Alfa; Hyaluronidase
Glofitamab
Niraparib Tosylate Monohydrate; Abiraterone Acetate
Polyethylene Glycol 3350; Sodium, Magnesium Sulfate; Potassium, Sodium Chloride
Ritlecitinib Tosylate
Rozanolixizumab

FDA Approval Documents:

339 new FDA Approval Documents
4,948 new pages of FDA Approval Documents

The new totals for PharmaPendium are:

3,086,123 pages of FDA Approval documents (Including FDA Classic Collection)
149,640 documents of FDA Approval documents (Including FDA Classic Collection)
4,888 drugs with data in PharmaPendium
2,433,653 extracted safety data lines
2,323,660 extracted PK data lines
606,945 extracted ME data lines
3,911,601 extracted Efficacy data lines
184,226 extracted Activity data lines
20,616,846 FAERS (post-marketing) reports
18,672 documents / 394,908 pages of EMA Approval documents
21,352 documents / 811,798 pages of FDA Advisory Committees Meetings documents
10,906 documents / 308,149 pages of FDA Classic Collection
2,769 documents / 32,290 pages of DESI documents

PharmaPendium 2023.13 Release

The content release includes the following updates:

2 new drugs in PharmaPendium

Cipaglucosidase Alfa
Vadadustat

FDA Approval Documents:

463 new FDA Approval Documents
6,367 new pages of FDA Approval Documents

EMA Documents:

106 new EMA documents
715 updated EMA documents
4,177 new pages of EMA Documents

Extracted PK data observations:

6,261 new extracted PK data lines

Extracted Safety data observations:

9,114 new extracted safety data lines

Metabolizing Enzymes Database:

5,797 new ME extracted data lines

Published Toxicity Database:

530 new safety records

Efficacy Database:

27,094 new extracted data lines

The new totals for PharmaPendium are:

3,081,175 pages of FDA Approval documents (Including FDA Classic Collection)
149,301 documents of FDA Approval documents (Including FDA Classic Collection)
4,882 drugs with data in PharmaPendium
2,433,653 extracted safety data lines
2,323,713 extracted PK data lines
606,659 extracted ME data lines
3,911,601 extracted Efficacy data lines
184,226 extracted Activity data lines
20,616,627 FAERS (post-marketing) reports
18,672 documents / 394,908 pages of EMA Approval documents
21,352 documents / 811,798 pages of FDA Advisory Committees Meetings documents
10,906 documents / 308,149 pages of FDA Classic Collection
2,769 documents / 32,290 pages of DESI documents

PharmaPendium 2023.12 Release

The content release includes the following updates:

9 new drugs in PharmaPendium

Epcoritamab
Fecal Microbiota Spores, Live
Fezolinetant
Flotufolastat F-18
Omidubicel
Pegunigalsidase Alfa
Perfluorohexyloctane
Sulbactam; Durlobactam
Tropicamide; Phenylephrine Hydrochloride

FDA Approval Documents:

410 new FDA Approval Documents
5,192 new pages of FDA Approval Documents

FDA Advisory Committee Documents:

255 new FDA Advisory Committee Documents
4,770 new pages of FDA Advisory Committee Documents

The new totals for PharmaPendium are:

3,074,808 pages of FDA Approval documents (Including FDA Classic Collection)
148,838 documents of FDA Approval documents (Including FDA Classic Collection)
4,880 drugs with data in PharmaPendium
2,424,009 extracted safety data lines
2,317,452 extracted PK data lines
600,862 extracted ME data lines
3,884,507 extracted Efficacy data lines
184,226 extracted Activity data lines
20,616,625 FAERS (post-marketing) reports
18,566 documents / 390,731 pages of EMA Approval documents
21,352 documents / 811,798 pages of FDA Advisory Committees Meetings documents
10,906 documents / 308,149 pages of FDA Classic Collection
2,769 documents / 32,290 pages of DESI documents

PharmaPendium 2023.11 Release

The content release includes the following updates:

FDA Approval Documents:

153 new FDA Approval Documents
2,320 new pages of FDA Approval Documents

EMA Documents:

68 new EMA documents
2,575 new pages of EMA Documents

Extracted PK data observations:

3,856 new extracted PK data lines

Extracted Safety data observations:

4,114 new extracted safety data lines

Metabolizing Enzymes Database:

1,909 new ME extracted data lines

Published Toxicity Database:

410 new safety records

The new totals for PharmaPendium are:

3,069,616 pages of FDA Approval documents (Including FDA Classic Collection)
148,428 documents of FDA Approval documents (Including FDA Classic Collection)
4,871 drugs with data in PharmaPendium
2,424,009 extracted safety data lines
2,317,452 extracted PK data lines
600,862 extracted ME data lines
3,884,507 extracted Efficacy data lines
184,226 extracted Activity data lines
20,616,625 FAERS (post-marketing) reports
18,566 documents / 390,731 pages of EMA Approval documents
21,097 documents / 807,028 pages of FDA Advisory Committees Meetings documents
10,906 documents / 308,149 pages of FDA Classic Collection
2,769 documents / 32,290 pages of DESI documents

PharmaPendium 2023.10 Release

The content release includes the following updates:

2 new drugs in PharmaPendium

Respiratory Syncytial Virus Vaccine, Adjuvanted
Tofersen

FDA Approval Documents:

327 new FDA Approval Documents
4,827 new pages of FDA Approval Documents

FAERS:

426,722 new FAERS reports

The new totals for PharmaPendium are:

3,067,296 pages of FDA Approval documents (Including FDA Classic Collection)
148,275 documents of FDA Approval documents (Including FDA Classic Collection)
4,871 drugs with data in PharmaPendium
2,419,485 extracted safety data lines
2,313,596 extracted PK data lines
598,953 extracted ME data lines
3,884,507 extracted Efficacy data lines
184,226 extracted Activity data lines
20,616,625 FAERS (post-marketing) reports
18,498 documents / 388,156 pages of EMA Approval documents
21,097 documents / 807,028 pages of FDA Advisory Committees Meetings documents
10,906 documents / 308,149 pages of FDA Classic Collection
2,769 documents / 32,290 pages of DESI documents

PharmaPendium 2023.09 Release

The content release includes the following updates:

1 new drug in PharmaPendium

COVID-19 Vaccine (Hipra)

FDA Approval Documents:

283 new FDA Approval Documents
4,037 new pages of FDA Approval Documents
106 new EMA documents
548 updated EMA documents
3,364 new pages of EMA Documents

Extracted PK data observations:

7,071 new extracted PK data lines

Extracted Safety data observations:

8,539 new extracted safety data lines

Metabolizing Enzymes Database:

4,731 new ME extracted data lines

Published Toxicity Database:

547 new safety records

Efficacy Database:

23,879 new extracted data lines

The new totals for PharmaPendium are:

3,062,469 pages of FDA Approval documents (Including FDA Classic Collection)
147,948 documents of FDA Approval documents (Including FDA Classic Collection)
4,869 drugs with data in PharmaPendium
2,419,485 extracted safety data lines
2,313,596 extracted PK data lines
598,957 extracted ME data lines
3,884,507 extracted Efficacy data lines
184,226 extracted Activity data lines
20,189,903 FAERS (post-marketing) reports
18,498 documents / 388,156 pages of EMA Approval documents
21,097 documents / 807,028 pages of FDA Advisory Committees Meetings documents
10,906 documents / 308,149 pages of FDA Classic Collection
2,769 documents / 32,290 pages of DESI documents

PharmaPendium 2023.08 Release

The content release includes the following updates:

8 new drugs in PharmaPendium

Antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein-ehtl
Leniolisib Phosphate
Nadofaragene Firadenovec
Omaveloxolone
Retifanlimab
Rezafungin
Trofinetide
Zavegepant Hydrochloride

FDA Approval Documents:

303 new FDA Approval Documents
3,744 new pages of FDA Approval Documents

FDA Advisory Committee Documents:

114 new FDA Advisory Committee Documents
3,190 new pages of FDA Advisory Committee Documents

The new totals for PharmaPendium are:

3,058,432 pages of FDA Approval documents (Including FDA Classic Collection)
147,665 documents of FDA Approval documents (Including FDA Classic Collection)
4,868 drugs with data in PharmaPendium
2,410,399 extracted safety data lines
2,306,525 extracted PK data lines
594,226 extracted ME data lines
3,860,628 extracted Efficacy data lines
184,226 extracted Activity data lines
20,189,903 FAERS (post-marketing) reports
18,392 documents / 384,792 pages of EMA Approval documents
21,097 documents / 807,028 pages of FDA Advisory Committees Meetings documents
10,906 documents / 308,149 pages of FDA Classic Collection
2,769 documents / 32,290 pages of DESI documents

PharmaPendium 2023.07 Release

The content release includes the following updates:

FDA Approval Documents:

393 new FDA Approval Documents
4,966 new pages of FDA Approval Documents

EMA Documents:

63 new EMA documents
3,443 new pages of EMA Documents

Extracted PK data observations:

4,256 new extracted PK data lines

Extracted Safety data observations:

4,490 new extracted safety data lines

Metabolizing Enzymes Database:

3,726 new ME extracted data lines

Published Toxicity Database:

600 new safety records

The new totals for PharmaPendium are:

3,054,688 pages of FDA Approval documents (Including FDA Classic Collection)
147,362 documents of FDA Approval documents (Including FDA Classic Collection)
4,860 drugs with data in PharmaPendium
2,410,399 extracted safety data lines
2,306,525 extracted PK data lines
594,226 extracted ME data lines
3,860,628 extracted Efficacy data lines
184,226 extracted Activity data lines
20,189,903 FAERS (post-marketing) reports
18,392 documents / 384,792 pages of EMA Approval documents
20,983 documents / 803,838 pages of FDA Advisory Committees Meetings documents
10,906 documents / 308,149 pages of FDA Classic Collection
2,769 documents / 32,290 pages of DESI documents

PharmaPendium 2023.06 Release

The content release includes the following updates:

6 new drugs in PharmaPendium

Daprodustat
Deutetrabenzine
Neostigmine Methylsulfate; Glycopyrrolate
Phenobarbital Sodium
Pirtobrutinib
Sparsentan

FDA Approval Documents:

413 new FDA Approval Documents
5,759 new pages of FDA Approval Documents

The new totals for PharmaPendium are:

3,049,722 pages of FDA Approval documents (Including FDA Classic Collection)
146,969 documents of FDA Approval documents (Including FDA Classic Collection)
4,860 drugs with data in PharmaPendium
2,405,309 extracted safety data lines
2,302,269 extracted PK data lines
590,500 extracted ME data lines
3,860,628 extracted Efficacy data lines
184,226 extracted Activity data lines
20,189,903 FAERS (post-marketing) reports
18,329 documents / 381,349 pages of EMA Approval documents
20,983 documents / 803,838 pages of FDA Advisory Committees Meetings documents
10,906 documents / 308,149 pages of FDA Classic Collection
2,769 documents / 32,290 pages of DESI documents

PharmaPendium 2023.05 Release

The content release includes the following updates:

1 new drug in PharmaPendium

Tabelecleucel

FDA Approval Documents:

327 new FDA Approval Documents
4,947 new pages of FDA Approval Documents

EMA Documents:

79 new EMA documents
689 updated EMA documents
1,858 new pages of EMA Documents

Extracted PK data observations:

4,699 new extracted PK data lines

Extracted Safety data observations:

13,102 new extracted safety data lines

Metabolizing Enzymes Database:

5,051 new ME extracted data lines

Published Toxicity Database:

385 new safety records

Efficacy Database:

46,863 new extracted data lines

The new totals for PharmaPendium are:

3,043,963 pages of FDA Approval documents (Including FDA Classic Collection)
146,556 documents of FDA Approval documents (Including FDA Classic Collection)
4,854 drugs with data in PharmaPendium
2,405,309 extracted safety data lines
2,302,269 extracted PK data lines
590,520 extracted ME data lines
3,860,628 extracted Efficacy data lines
184,226 extracted Activity data lines
20,189,868 FAERS (post-marketing) reports
18,329 documents / 381,349 pages of EMA Approval documents
20,983 documents / 803,838 pages of FDA Advisory Committees Meetings documents
10,906 documents / 308,149 pages of FDA Classic Collection
2,769 documents / 32,290 pages of DESI documents

PharmaPendium 2023.04 Release

The content release includes the following updates:

7 new drugs in PharmaPendium

Albuterol; Budesonide
Anacaulase
Bexagliflozin
Elacestrant
Lecanemab
Ublituximab
Xenon Xe-129 Hyperpolarized

FDA Approval Documents:

223 new FDA Approval Documents
3,533 new pages of FDA Approval Documents

FDA Advisory Committee Documents:

90 new FDA Advisory Committee Documents
3,178 new pages of FDA Advisory Committee Documents

FAERS:

484,816 new FAERS reports (2022_Q4)

The new totals for PharmaPendium are:

3,039,016 pages of FDA Approval documents (Including FDA Classic Collection)
146,229 documents of FDA Approval documents (Including FDA Classic Collection)
4,853 drugs with data in PharmaPendium
2,391,822 extracted safety data lines
2,297,570 extracted PK data lines
585,469 extracted ME data lines
3,813,765 extracted Efficacy data lines
184,226 extracted Activity data lines
20,189,868 FAERS (post-marketing) reports
18,250 documents / 379,491 pages of EMA Approval documents
20,983 documents / 803,838 pages of FDA Advisory Committees Meetings documents
10,906 documents / 308,149 pages of FDA Classic Collection
2,769 documents / 32,290 pages of DESI documents

PharmaPendium 2023.03 Release

The content release includes the following updates:

FDA Approval Documents:

241 new FDA Approval Documents
3,582 new pages of FDA Approval Documents

EMA Documents:

143 new EMA documents
6,849 new pages of EMA Documents

Extracted PK data observations:

4,902 new extracted PK data lines

Extracted Safety data observations:

4,444 new extracted safety data lines

Metabolizing Enzymes Database:

3,182 new ME extracted data lines

Published Toxicity Database:

433 new safety records

The new totals for PharmaPendium are:

3,035,483 pages of FDA Approval documents (Including FDA Classic Collection)
146,006 documents of FDA Approval documents (Including FDA Classic Collection)
4,846 drugs with data in PharmaPendium
2,391,822 extracted safety data lines
2,297,661 extracted PK data lines
585,596 extracted ME data lines
3,813,765 extracted Efficacy data lines
184,226 extracted Activity data lines
19,705,052 FAERS (post-marketing) reports
18,250 documents / 379,491 pages of EMA Approval documents
20,893 documents / 800,660 pages of FDA Advisory Committees Meetings documents
10,906 documents / 308,149 pages of FDA Classic Collection
2,769 documents / 32,290 pages of DESI documents

PharmaPendium 2023.02 Release

The content release includes the following updates:

4 new drugs in PharmaPendium

Adagrasib
Etranacogene Dezaparvovec
Fecal Microbiota, Live
Olutasidenib

FDA Approval Documents:

416 new FDA Approval Documents
4,496 new pages of FDA Approval Documents

The new totals for PharmaPendium are:

3,031,901 pages of FDA Approval documents (Including FDA Classic Collection)
145,765 documents of FDA Approval documents (Including FDA Classic Collection)
4,846 drugs with data in PharmaPendium
2,386,945 extracted safety data lines
2,292,759 extracted PK data lines
582,414 extracted ME data lines
3,813,765 extracted Efficacy data lines
184,226 extracted Activity data lines
19,705,052 FAERS (post-marketing) reports
18,107 documents / 372,642 pages of EMA Approval documents
20,893 documents / 800,660 pages of FDA Advisory Committees Meetings documents
10,906 documents / 308,149 pages of FDA Classic Collection
2,769 documents / 32,290 pages of DESI documents

PharmaPendium 2023.01 Release

The content release includes the following updates:

2 new drugs in PharmaPendium

COVID-19 Vaccine (Vidprevtyn Beta)
Nirsevimab

FDA Approval Documents:

568 new FDA Approval Documents
6,671 new pages of FDA Approval Documents

EMA Documents:

101 new EMA documents
629 updated EMA documents
3,290 new pages of EMA Documents

Extracted PK data observations:

5,898 new extracted PK data lines

Extracted Safety data observations:

16,452 new extracted safety data lines

Metabolizing Enzymes Database:

8,272 new ME extracted data lines

Published Toxicity Database:

524 new safety records

Efficacy Database:

35,670 new extracted data lines

The new totals for PharmaPendium are:

3,027,405 pages of FDA Approval documents (Including FDA Classic Collection)
145,349 documents of FDA Approval documents (Including FDA Classic Collection)
4,842 drugs with data in PharmaPendium
2,386,945 extracted safety data lines
2,292,780 extracted PK data lines
582,536 extracted ME data lines
3,813,765 extracted Efficacy data lines
184,226 extracted Activity data lines
19,705,052 FAERS (post-marketing) reports
18,107 documents / 372,642 pages of EMA Approval documents
20,893 documents / 800,660 pages of FDA Advisory Committees Meetings documents
10,906 documents / 308,149 pages of FDA Classic Collection
2,769 documents / 32,290 pages of DESI documents

PharmaPendium 2022.24 Release

The content release includes the following updates:

2 new drugs in PharmaPendium

Mirvetuximab Soravtansine
Teplizumab

FDA Approval Documents:

199 new FDA Approval Documents
2,994 new pages of FDA Approval Documents

FDA Advisory Committee Documents:

143 new FDA Advisory Committee Documents
4,398 new pages of FDA Advisory Committee Documents

The new totals for PharmaPendium are:

3,020,734 pages of FDA Approval documents (Including FDA Classic Collection)
144,781 documents of FDA Approval documents (Including FDA Classic Collection)
4,840 drugs with data in PharmaPendium
2,369,969 extracted safety data lines
2,286,882 extracted PK data lines
574,264 extracted ME data lines
3,778,095 extracted Efficacy data lines
184,226 extracted Activity data lines
19,705,052 FAERS (post-marketing) reports
18,006 documents / 369,352 pages of EMA Approval documents
20,893 documents / 800,660 pages of FDA Advisory Committees Meetings documents
10,906 documents / 308,149 pages of FDA Classic Collection
2,769 documents / 32,290 pages of DESI documents

PharmaPendium 2022.23 Release

The content release includes the following updates:

FDA Approval Documents:

213 new FDA Approval Documents
2,535 new pages of FDA Approval Documents

EMA Documents:

81 new EMA documents
2,293 new pages of EMA Documents

Extracted PK data observations:

3,497 new extracted PK data lines

Extracted Safety data observations:

6,917 new extracted safety data lines

Metabolizing Enzymes Database:

1,113 new ME extracted data lines

Published Toxicity Database:

503 new safety records

The new totals for PharmaPendium are:

3,017,740 pages of FDA Approval documents (Including FDA Classic Collection)
144,582 documents of FDA Approval documents (Including FDA Classic Collection)
4,838 drugs with data in PharmaPendium
2,369,770 extracted safety data lines
2,286,518 extracted PK data lines
574,264 extracted ME data lines
3,776,644 extracted Efficacy data lines
184,226 extracted Activity data lines
19,705,052 FAERS (post-marketing) reports
18,006 documents / 369,317 pages of EMA Approval documents
20,750 documents / 796,262 pages of FDA Advisory Committees Meetings documents
10,906 documents / 308,149 pages of FDA Classic Collection
2,769 documents / 32,290 pages of DESI documents

PharmaPendium 2022.22 Release

The content release includes the following updates:

3 new drugs in PharmaPendium

Futibatinib
Teclistamab
Tremelimumab

FDA Approval Documents:

295 new FDA Approval Documents
4,418 new pages of FDA Approval Documents

FAERS:

443,265 new FAERS reports (2022_Q3)

The new totals for PharmaPendium are:

3,015,205 pages of FDA Approval documents (Including FDA Classic Collection)
144,369 documents of FDA Approval documents (Including FDA Classic Collection)
4,838 drugs with data in PharmaPendium
2,362,350 extracted safety data lines
2,283,021 extracted PK data lines
573,151 extracted ME data lines
3,776,644 extracted Efficacy data lines
184,226 extracted Activity data lines
19,705,052 FAERS (post-marketing) reports
17,925 documents / 367,024 pages of EMA Approval documents
20,750 documents / 796,262 pages of FDA Advisory Committees Meetings documents
10,906 documents / 308,149 pages of FDA Classic Collection
2,769 documents / 32,290 pages of DESI documents

PharmaPendium 2022.21 Release

The content release includes the following updates:

1 new drug in PharmaPendium

Valoctocogene Roxaparvovec

FDA Approval Documents:

480 new FDA Approval Documents
8,407 new pages of FDA Approval Documents

EMA Documents:

100 new EMA documents
768 updated EMA documents
3,344 new pages of EMA Documents

Extracted PK data observations:

4,966 new extracted PK data lines

Extracted Safety data observations:

9,907 new extracted safety data lines

Metabolizing Enzymes Database:

7,500 new ME extracted data lines

Published Toxicity Database:

265 new safety records

Efficacy Database:

27,875 new extracted data lines

The new totals for PharmaPendium are:

3,010,787 pages of FDA Approval documents (Including FDA Classic Collection)
144,074 documents of FDA Approval documents (Including FDA Classic Collection)
4,835 drugs with data in PharmaPendium
2,362,350 extracted safety data lines
2,283,021 extracted PK data lines
573,133 extracted ME data lines
3,776,644 extracted Efficacy data lines
184,226 extracted Activity data lines
19,261,787 FAERS (post-marketing) reports
17,925 documents / 367,024 pages of EMA Approval documents
20,750 documents / 796,262 pages of FDA Advisory Committees Meetings documents
10,906 documents / 308,149 pages of FDA Classic Collection
2,769 documents / 32,290 pages of DESI documents

PharmaPendium 2022.20 Release

The content release includes the following updates:

6 new drugs in PharmaPendium

Daxibotulinumtoxina
Deucravacitinib
Eflapegrastim
Gadopiclenol
Omidenepag Isopropyl
Sodium Phenylbutyrate; Sodium Taurursodiol

FDA Approval Documents:

316 new FDA Approval Documents
4,548 new pages of FDA Approval Documents

FDA Advisory Committee Documents:

101 new FDA Advisory Committee Documents
3,297 new pages of FDA Advisory Committee Documents

The new totals for PharmaPendium are:

3,002,380 pages of FDA Approval documents (Including FDA Classic Collection)
143,594 documents of FDA Approval documents (Including FDA Classic Collection)
4,834 drugs with data in PharmaPendium
2,352,178 extracted safety data lines
2,278,055 extracted PK data lines
565,633 extracted ME data lines
3,748,769 extracted Efficacy data lines
184,226 extracted Activity data lines
19,261,787 FAERS (post-marketing) reports
17,825 documents / 363,680 pages of EMA Approval documents
20,750 documents / 796,262 pages of FDA Advisory Committees Meetings documents
10,906 documents / 308,149 pages of FDA Classic Collection
2,769 documents / 32,290 pages of DESI documents

PharmaPendium 2022.19 Release

The content release includes the following updates:

3 new drugs in PharmaPendium

Eladocagene Exuparvovec
Lenacapavir Sodium
Sitagliptin Hydrochloride; Metformin Hydrochloride

FDA Approval Documents:

228 new FDA Approval Documents
2,919 new pages of FDA Approval Documents

EMA Documents:

98 new EMA documents
2,927 new pages of EMA Documents

Extracted PK data observations:

5,348 new extracted PK data lines

Extracted Safety data observations:

4,066 new extracted safety data lines

Metabolizing Enzymes Database:

2,880 new ME extracted data lines

Published Toxicity Database:

784 new safety records

The new totals for PharmaPendium are:

2,997,832 pages of FDA Approval documents (Including FDA Classic Collection)
143,278 documents of FDA Approval documents (Including FDA Classic Collection)
4,828 drugs with data in PharmaPendium
2,352,121 extracted safety data lines
2,278,055 extracted PK data lines
565,633 extracted ME data lines
3,748,769 extracted Efficacy data lines
184,226 extracted Activity data lines
19,261,787 FAERS (post-marketing) reports
17,825 documents / 363,680 pages of EMA Approval documents
20,649 documents / 792,965 pages of FDA Advisory Committees Meetings documents
10,906 documents / 308,149 pages of FDA Classic Collection
2,769 documents / 32,290 pages of DESI documents

PharmaPendium 2022.18 Release

The content release includes the following updates:

2 new drugs in PharmaPendium

Bupropion Hydrochloride; Dextromethorphan Hydrobromide
Spesolimab

FDA Approval Documents:

175 new FDA Approval Documents
1,982 new pages of FDA Approval Documents

The new totals for PharmaPendium are:

2,994,913 pages of FDA Approval documents (Including FDA Classic Collection)
143,050 documents of FDA Approval documents (Including FDA Classic Collection)
4,825 drugs with data in PharmaPendium
2,347,271 extracted safety data lines
2,272,707 extracted PK data lines
562,753 extracted ME data lines
3,748,769 extracted Efficacy data lines
184,226 extracted Activity data lines
19,261,787 FAERS (post-marketing) reports
17,727 documents / 360,753 pages of EMA Approval documents
20,649 documents / 792,965 pages of FDA Advisory Committees Meetings documents
10,906 documents / 308,149 pages of FDA Classic Collection
2,769 documents / 32,290 pages of DESI documents

PharmaPendium 2022.17 Release

The content release includes the following updates:

7 new drugs in PharmaPendium

Betula Pendula Roth; Betula Pubescens Ehrh.
COVID-19 Vaccine (Valneva)
Leuprorelin Mesilate
Linzagolix Choline
Mosunetuzumab
Olipudase Alfa
Sitagliptin Hydrochloride Monohydrate

FDA Approval Documents:

232 new FDA Approval Documents
3,856 new pages of FDA Approval Documents

EMA Documents:

175 new EMA documents
472 updated EMA documents
3,952 new pages of EMA Documents

Extracted PK data observations:

9,784 new extracted PK data lines

Extracted Safety data observations:

7,559 new extracted safety data lines

Metabolizing Enzymes Database:

5,746 new ME extracted data lines

Published Toxicity Database:

533 new safety records

Efficacy Database:

37,519 new extracted data lines

The new totals for PharmaPendium are:

2,992,931 pages of FDA Approval documents (Including FDA Classic Collection)
142,875 documents of FDA Approval documents (Including FDA Classic Collection)
4,823 drugs with data in PharmaPendium
2,343,722 extracted safety data lines
2,272,723 extracted PK data lines
562,753 extracted ME data lines
3,748,769 extracted Efficacy data lines
184,226 extracted Activity data lines
19,261,787 FAERS (post-marketing) reports
17,727 documents / 360,753 pages of EMA Approval documents
20,649 documents / 792,965 pages of FDA Advisory Committees Meetings documents
10,906 documents / 308,149 pages of FDA Classic Collection
2,769 documents / 32,290 pages of DESI documents

PharmaPendium 2022.16 Release

The content release includes the following updates:

2 new drugs in PharmaPendium

Levoketoconazole
Venlafaxine Besylate Monohydrate

FDA Approval Documents:

371 new FDA Approval Documents
4,368 new pages of FDA Approval Documents

FDA Advisory Committee Documents:

178 new FDA Advisory Committee Documents
5,958 new pages of FDA Advisory Committee Documents

FAERS:

432,610 new FAERS reports (2022_Q2)

The new totals for PharmaPendium are:

2,989,075 pages of FDA Approval documents (Including FDA Classic Collection)
142,643 documents of FDA Approval documents (Including FDA Classic Collection)
4,816 drugs with data in PharmaPendium
2,335,631 extracted safety data lines
2,262,939 extracted PK data lines
557,007 extracted ME data lines
3,711,250 extracted Efficacy data lines
184,226 extracted Activity data lines
19,261,732 FAERS (post-marketing) reports
17,552 documents / 356,801 pages of EMA Approval documents
20,649 documents / 792,965 pages of FDA Advisory Committees Meetings documents
10,906 documents / 308,149 pages of FDA Classic Collection
2,769 documents / 32,290 pages of DESI documents

PharmaPendium 2022.15 Release

The content release includes the following updates:

FDA Approval Documents:

669 new FDA Approval Documents
7,691 new pages of FDA Approval Documents

EMA Documents:

96 new EMA documents
2,027 new pages of EMA Documents

Extracted PK data observations:

5,500 new extracted PK data lines

Extracted Safety data observations:

4,299 new extracted safety data lines

Metabolizing Enzymes Database:

763 new ME extracted data lines

Published Toxicity Database:

457 new safety records

The new totals for PharmaPendium are:

2,984,707 pages of FDA Approval documents (Including FDA Classic Collection)
142,272 documents of FDA Approval documents (Including FDA Classic Collection)
4,814 drugs with data in PharmaPendium
2,335,631 extracted safety data lines
2,262,939 extracted PK data lines
557,007 extracted ME data lines
3,711,250 extracted Efficacy data lines
184,226 extracted Activity data lines
18,829,122 FAERS (post-marketing) reports
17,552 documents / 356,801 pages of EMA Approval documents
20,471 documents / 787,007 pages of FDA Advisory Committees Meetings documents
10,906 documents / 308,149 pages of FDA Classic Collection
2,769 documents / 32,290 pages of DESI documents

PharmaPendium 2022.14 Release

The content release includes the following updates:

1 new drugs in PharmaPendium

Vutrisiran

FDA Approval Documents:

417 new FDA Approval Documents
6,016 new pages of FDA Approval Documents

The new totals for PharmaPendium are:

2,977,016 pages of FDA Approval documents (Including FDA Classic Collection)
141,603 documents of FDA Approval documents (Including FDA Classic Collection)
4,814 drugs with data in PharmaPendium
2,330,875 extracted safety data lines
2,257,439 extracted PK data lines
556,244 extracted ME data lines
3,711,250 extracted Efficacy data lines
184,226 extracted Activity data lines
18,829,122 FAERS (post-marketing) reports
17,456 documents / 354,774 pages of EMA Approval documents
20,471 documents / 787,007 pages of FDA Advisory Committees Meetings documents
10,906 documents / 308,149 pages of FDA Classic Collection
2,769 documents / 32,290 pages of DESI documents

PharmaPendium 2022.13 Release

The content release includes the following updates:

FDA Approval Documents:

703 new FDA Approval Documents
7,391 new pages of FDA Approval Documents

EMA Documents:

86 new EMA documents
639 updated EMA documents
2,416 new pages of EMA Documents

Extracted PK data observations:

20,954 new extracted PK data lines

Extracted Safety data observations:

8,116 new extracted safety data lines

Metabolizing Enzymes Database:

3,810 new ME extracted data lines

Published Toxicity Database:

754 new safety records

Efficacy Database:

31,206 new extracted data lines

The new totals for PharmaPendium are:

2,971,000 pages of FDA Approval documents (Including FDA Classic Collection)
141,186 documents of FDA Approval documents (Including FDA Classic Collection)
4,813 drugs with data in PharmaPendium
2,331,161 extracted safety data lines
2,257,497 extracted PK data lines
556,144 extracted ME data lines
3,711,276 extracted Efficacy data lines
184,226 extracted Activity data lines
18,829,122 FAERS (post-marketing) reports
17,458 documents / 354,874 pages of EMA Approval documents
20,471 documents / 787,007 pages of FDA Advisory Committees Meetings documents
10,906 documents / 308,149 pages of FDA Classic Collection
2,769 documents / 32,290 pages of DESI documents

PharmaPendium 2022.12 Release

The content release includes the following updates:

8 new drugs in PharmaPendium

Amoxicillin; Clarithromycin; Vonoprazan
Amoxicillin; Vonoprazan
Lisocabtagene Maraleucel
Mavacamten
Oteseconazole
Tapinarof
Tirzepatide
Tixagevimab; Cilgavimab

FDA Approval Documents:

879 new FDA Approval Documents
11,068 new pages of FDA Approval Documents

FDA Advisory Committee Documents:

76 new FDA Advisory Committee Documents
2,324 new pages of FDA Advisory Committee Documents

EMA Documents:

111 new EMA documents
3,190 new pages of EMA Documents

New Meyler’s Documents and Safety data observations:

1,436 New Meyler’s documents
6,295 pages of New Meyler’s Documents
105,517 New Meyler’s extracted safety data lines

Extracted PK data observations:

2,863 new extracted PK data lines

Extracted Safety data observations:

4,537 new extracted safety data lines

Metabolizing Enzymes Database:

1,151 new ME extracted data lines

Published Toxicity Database:

726 new safety records

The new totals for PharmaPendium are:

2,963,609 pages of FDA Approval documents (Including FDA Classic Collection)
140,483 documents of FDA Approval documents (Including FDA Classic Collection)
4,813 drugs with data in PharmaPendium
2,354,793 extracted safety data lines
2,236,543 extracted PK data lines
552,334 extracted ME data lines
3,680,070 extracted Efficacy data lines
184,226 extracted Activity data lines
18,829,122 FAERS (post-marketing) reports
17,372 documents / 352,458 pages of EMA Approval documents
20,471 documents / 787,007 pages of FDA Advisory Committees Meetings documents
10,906 documents / 308,149 pages of FDA Classic Collection
2,769 documents / 32,290 pages of DESI documents

PharmaPendium 2022.10 Release

The content release includes the following updates:

FDA Approval Documents:

420 new FDA Approval Documents
6,115 new pages of FDA Approval Documents

FAERS:

457,110 new FAERS reports (2022_Q1)

The new totals for PharmaPendium are:

2,952,541 pages of FDA Approval documents (Including FDA Classic Collection)
139,604 documents of FDA Approval documents (Including FDA Classic Collection)
4,805 drugs with data in PharmaPendium
2,317,045 extracted safety data lines
2,233,680 extracted PK data lines
551,183 extracted ME data lines
3,681,160 extracted Efficacy data lines
184,226 extracted Activity data lines
18,828,706 FAERS (post-marketing) reports
17,261 documents / 349,268 pages of EMA Approval documents
20,395 documents / 784,683 pages of FDA Advisory Committees Meetings documents
10,906 documents / 308,149 pages of FDA Classic Collection
2,769 documents / 32,290 pages of DESI documents

PharmaPendium 2022.09 Release

The content release includes the following updates:

2 new drugs in PharmaPendium

Ciltacabtagene Autoleucel
Somatrogon

FDA Approval Documents:

294 new FDA Approval Documents
4,669 new pages of FDA Approval Documents

EMA Documents:

93 new EMA documents
818 updated EMA documents
2,280 new pages of EMA Documents

Extracted PK data observations:

7,166 new extracted PK data lines

Extracted Safety data observations:

11,903 new extracted safety data lines

Metabolizing Enzymes Database:

2,713 new ME extracted data lines

Published Toxicity Database:

620 new safety records

Efficacy Database:

37,371 new extracted data lines

The new totals for PharmaPendium are:

2,946,426 pages of FDA Approval documents (Including FDA Classic Collection)
139,184 documents of FDA Approval documents (Including FDA Classic Collection)
4,805 drugs with data in PharmaPendium
2,317,045 extracted safety data lines
2,233,680 extracted PK data lines
551,183 extracted ME data lines
3,681,160 extracted Efficacy data lines
184,226 extracted Activity data lines
18,371,596 FAERS (post-marketing) reports
17,261 documents / 349,268 pages of EMA Approval documents
20,395 documents / 784,683 pages of FDA Advisory Committees Meetings documents
10,906 documents / 308,149 pages of FDA Classic Collection
2,769 documents / 32,290 pages of DESI documents

PharmaPendium 2022.08 Release

The content release includes the following updates:

5 new drugs in PharmaPendium

Dextroamphetamine
Ganaxolone
Lutetium (177Lu) Vipivotide Tetraxetan
Nivolumab; Relatlimab
Pacritinib Citrate

FDA Approval Documents:

142 new FDA Approval Documents
2,416 new pages of FDA Approval Documents

FDA Advisory Committee Documents:

51 new FDA Advisory Committee Documents
1,838 new pages of FDA Advisory Committee Documents

The new totals for PharmaPendium are:

2,941,757 pages of FDA Approval documents (Including FDA Classic Collection)
138,890 documents of FDA Approval documents (Including FDA Classic Collection)
4,803 drugs with data in PharmaPendium
2,304,522 extracted safety data lines
2,226,514 extracted PK data lines
548,470 extracted ME data lines
3,643,789 extracted Efficacy data lines
184,226 extracted Activity data lines
18,370,019 FAERS (post-marketing) reports
17,168 documents / 346,988 pages of EMA Approval documents
20,395 documents / 784,683 pages of FDA Advisory Committees Meetings documents
10,906 documents / 308,149 pages of FDA Classic Collection
2,769 documents / 32,290 pages of DESI documents

PharmaPendium 2022.07 Release

The content release includes the following updates:

FDA Approval Documents:

223 new FDA Approval Documents
3,776 new pages of FDA Approval Documents

EMA Documents:

85 new EMA documents
2,372 new pages of EMA Documents

Extracted PK data observations:

6,218 new extracted PK data lines

Extracted Safety data observations:

3,763 new extracted safety data lines

Metabolizing Enzymes Database:

2,306 new ME extracted data lines

Published Toxicity Database:

265 new safety records

The new totals for PharmaPendium are:

2,939,341 pages of FDA Approval documents (Including FDA Classic Collection)
138,748 documents of FDA Approval documents (Including FDA Classic Collection)
4,798 drugs with data in PharmaPendium
2,304,522 extracted safety data lines
2,226,514 extracted PK data lines
548,470 extracted ME data lines
3,643,789 extracted Efficacy data lines
184,226 extracted Activity data lines
18,370,019 FAERS (post-marketing) reports
17,168 documents / 346,988 pages of EMA Approval documents
20,344 documents / 782,845 pages of FDA Advisory Committees Meetings documents
10,906 documents / 308,149 pages of FDA Classic Collection
2,769 documents / 32,290 pages of DESI documents

The content release includes the following updates:

3 new drugs in PharmaPendium

Etafilcon A Lens with Ketotifen
Mitapivat Sulfate
Sutimlimab

FDA Approval Documents:

263 new FDA Approval Documents
3,756 new pages of FDA Approval Documents

FAERS:

407,596 new FAERS reports (2021_Q4).

The new totals for PharmaPendium are:

2,935,565 pages of FDA Approval documents (Including FDA Classic Collection)
138,525 documents of FDA Approval documents (Including FDA Classic Collection)
4,798 drugs with data in PharmaPendium
2,300,494 extracted safety data lines
2,220,296 extracted PK data lines
546,164 extracted ME data lines
3,643,789 extracted Efficacy data lines
184,226 extracted Activity data lines
18,370,019 FAERS (post-marketing) reports
17,083 documents / 344,616 pages of EMA Approval documents
20,344 documents / 782,845 pages of FDA Advisory Committees Meetings documents
10,906 documents / 308,149 pages of FDA Classic Collection
2,769 documents / 32,290 pages of DESI documents

PharmaPendium 2021.22 Release

The content release includes the following updates:

3 new drugs in PharmaPendium

Asciminib hydrochloride
Avacopan
Celecoxib; Tramadol Hydrochloride

FDA Approval Documents:

341 new FDA Approval Documents
4,450 new pages of FDA Approval Documents

Extracted Safety data observations:

47,534 new extracted safety data lines

Published Toxicity Database:

715 new safety records

FAERS:

502,296 new FAERS reports (2021_Q3)

The new totals for PharmaPendium are:

2,907,307 pages of FDA Approval documents (Including FDA Classic Collection)
136,511 documents of FDA Approval documents (Including FDA Classic Collection)
4,775 drugs with data in PharmaPendium
2,267,359 extracted safety data lines
2,195,372 extracted PK data lines
532,932 extracted ME data lines
3,576,684 extracted Efficacy data lines
184,226 extracted Activity data lines
17,962,359 FAERS (post-marketing) reports
16,686 documents / 332,496 pages of EMA Approval documents
20,152 documents / 776,605 pages of FDA Advisory Committees Meetings documents
10,906 documents / 308,149 pages of FDA Classic Collection
2,769 documents / 32,290 pages of DESI documents

PharmaPendium 2022.01 Release

The content release includes the following updates:

1 new drug in PharmaPendium

Regdanvimab

FDA Approval Documents:

225 new FDA Approval Documents
2,784 new pages of FDA Approval Documents

EMA Documents:

110 new EMA documents
671 updated EMA documents
2,593 new pages of EMA Documents

Extracted PK data observations:

6,766 new extracted PK data lines

Extracted Safety data observations:

9,193 new extracted safety data lines

Metabolizing Enzymes Database:

2,856 new ME extracted data lines

Published Toxicity Database:

642 new safety records

Efficacy Database:

38,189 new extracted data lines

The new totals for PharmaPendium are:

2,916,139 pages of FDA Approval documents (Including FDA Classic Collection)
137,152 documents of FDA Approval documents (Including FDA Classic Collection)
4,779 drugs with data in PharmaPendium
2,282,531 extracted safety data lines
2,207,668 extracted PK data lines
539,815 extracted ME data lines
3,614,873 extracted Efficacy data lines
184,226 extracted Activity data lines
17,962,371 FAERS (post-marketing) reports
16,852 documents / 336,247 pages of EMA Approval documents
20,281 documents / 779,208 pages of FDA Advisory Committees Meetings documents
10,906 documents / 308,149 pages of FDA Classic Collection
2,769 documents / 32,290 pages of DESI documents

What are the current PharmaPendium content statistics?

What are the 2022-2023 PharmaPendium content statistics?

Did we answer your question?

Related answers

Recently viewed answers

For further assistance: